Skip to main content

URMC Logo

URMC / Research / Research@URMC
Day-long Wilmot Symposium Covers Cancer Biology, Latest Treatments (and whales!)

Day-long Wilmot Symposium Covers Cancer Biology, Latest Treatments (and whales!)

Exciting new studies of targeted cancer treatments, the amazing longevity of bowhead whales, and the changing roles of pathologists were among the topics covered at the 19th Annual Scientific Symposium sponsored by the Wilmot Cancer Institute on Nov. 13.

11/14/2014
Pathology Expert Shares Personalized Medicine Tool

Pathology Expert Shares Personalized Medicine Tool

UR Pathology Professor David G. Hicks, M.D., a national leader in using molecular technology to diagnose breast cancer, helped to design a new tool to assist other U.S. pathologists in how to personalize treatment for patients with invasive disease.

7/31/2014
Wilmot Cancer Institute Scientists Receive $2M from NCI

Wilmot Cancer Institute Scientists Receive $2M from NCI

The National Cancer Institute awarded more than $2 million to a team at the Wilmot Cancer Institute to continue their study of a gene network that controls cancer progression, with a focus on pancreatic cancer.

6/25/2014
Nature Gives Shout-Out to Wilmot for Immune Therapy Research

Nature Gives Shout-Out to Wilmot for Immune Therapy Research

One of the big topics in cancer research is immunotherapy and the need for a new generation of drugs that spur the immune system to fight tumors. John Frelinger’s lab was featured in a news article in the journal Nature, for its work on refining interleukin-2.

6/4/2014
Using Cancer’s Fingerprint, UR Researchers Clinch a Diagnosis

Using Cancer’s Fingerprint, UR Researchers Clinch a Diagnosis

Rochester scientists are using a gene test to diagnose a difficult-to-detect form of bone marrow cancer – an example of how academic medical centers are applying new technology in ways that play to their strengths to achieve better patient care.

3/5/2014